daddyinvesting.com
Dr. Agarwal’s Health Care Limited IPO: A Comprehensive Overview
Introduction
Dr. Agarwal’s Health Care Limited, a leading provider of eye care services in India, is launching its IPO. The company offers a wide range of services, including cataract and refractive surgeries, consultations, diagnostics, non-surgical treatments, and the sale of optical products, contact lenses, and pharmaceuticals.
As of September 30, 2024, the company operated with 737 doctors across its facilities, serving 2.13 million patients and performing 220,523 surgeries in the previous year. Between April and September 2024, they treated 1.15 million patients and conducted 140,787 surgeries.
Services Offered
- Cataract Surgeries
- Advanced treatments like phacoemulsification, robotic surgery, and glued intraocular lens procedures.
- Refractive Surgeries
- Corrective surgeries like LASIK, SMILE, and implantable collamer lenses to reduce dependence on glasses.
- Other Surgical Services
- Includes treatments for glaucoma, corneal transplants, retinal conditions, oculoplasty, and pinhole pupilloplasty.
Network and Presence
- Indian Operations: 28 hubs (including 3 Centers of Excellence) and 165 spokes across 117 cities in 14 states and 4 union territories.
- Facilities: A total of 193 centers as of September 2024.
Dr. Agarwal’s Health Care IPO Details
- Opening Date: January 29, 2025
- Closing Date: January 31, 2025
- Issue Type: Book Built Issue
- Size: ₹3,027.26 Crore (Fresh Issue: ₹300 Crore; Offer for Sale: ₹2,727.26 Crore)
- Price Band: ₹382–₹402 per share
- Market Lot: 35 shares
- Listing: BSE & NSE
- Registrar: KFin Technologies Limited
Key Financial Highlights
| Particulars | 2022 | 2023 | 2024 | H1 FY25 |
| Total Revenue | ₹713.78 Cr | ₹1,031.49 Cr | ₹1,376.44 Cr | ₹837.94 Cr |
| Total Expense | ₹657.02 Cr | ₹947.90 Cr | ₹1,235.88 Cr | ₹777.58 Cr |
| Profit After Tax | ₹43.16 Cr | ₹103.23 Cr | ₹95.05 Cr | ₹39.56 Cr |
| Total Borrowing | ₹290.18 Cr | ₹356.18 Cr | ₹387.79 Cr | ₹373.68 Cr |
Competitive Strengths
- India’s largest eye care service provider with a trusted brand.
- Comprehensive and scalable eye care solutions using a hub-and-spoke model.
- History of surgical innovations and proven clinical excellence.
- Led by experienced doctor-promoters and a strong management team.
Key Metrics
- Return on Equity (ROE): 9.33%
- Return on Capital Employed (ROCE): 14.61%
- PAT Margin: 6.90%
- Price to Book Value (PBV): 7.96
IPO Timeline
| Event | Date |
| IPO Open | January 29, 2025 |
| IPO Close | January 31, 2025 |
| Allotment Basis | February 3, 2025 |
| Refund Initiation | February 4, 2025 |
| Shares Credited | February 4, 2025 |
| Listing Date | February 5, 2025 |
Lot Sizes
| Category | Lots | Shares | Amount (₹) |
| Retail (Min) | 1 | 35 | ₹14,070 |
| Retail (Max) | 14 | 490 | ₹1,96,980 |
| S-HNI (Min) | 15 | 525 | ₹2,11,050 |
| B-HNI (Min) | 72 | 2,520 | ₹10,13,040 |
Promoters
Key promoters include:
- Dr. Amar Agarwal
- Dr. Athiya Agarwal
- Dr. Adil Agarwal, and others from the Agarwal family.
Peer Comparison
| Company Name | P/E Ratio |
| Apollo Hospitals Enterprise Limited | 107.11 |
| Fortis Healthcare Limited | 82.11 |
| Aster DM Healthcare Limited | 136.07 |
Objectives of the IPO
- Repayment/prepayment of borrowings.
- General corporate purposes and acquisitions.
Dr. Agarwal’s Health Care Limited’s IPO presents a promising investment opportunity with its robust network, comprehensive services, and consistent financial growth.
FAQs about Dr. Agarwal’s Health Care Limited IPO
- What is the Dr. Agarwal’s Health Care Limited IPO?
The Dr. Agarwal’s Health Care Limited IPO is an initial public offering where the company is offering its shares to the public for the first time. The funds raised will support its growth, expansion, and other strategic goals.
- What does Dr. Agarwal’s Health Care Limited specialize in?
Dr. Agarwal’s Health Care Limited specializes in eye care services, including cataract surgeries, refractive surgeries, consultations, diagnostic services, and the sale of optical products, contact lenses, and eye-related pharmaceutical items.
- What are the objectives of the IPO?
The primary objectives of the IPO may include funding new facility expansions, upgrading technology, reducing debt, and supporting operational growth initiatives.
- What is the financial performance of Dr. Agarwal’s Health Care Limited?
As of September 30, 2024, the company had served 2.13 million patients and performed 220,523 surgeries. Detailed financial performance metrics can be found in the IPO prospectus.
- How can I apply for the Dr. Agarwal’s Health Care Limited IPO?
You can apply for the IPO through your stockbroker or by using online trading platforms. Ensure you have a Demat account to receive the shares.
- What are the risks associated with investing in the IPO?
Risks may include market volatility, regulatory changes, industry competition, and the company’s ability to maintain its growth trajectory. It’s essential to review the Risk Factors section in the IPO prospectus before investing.
- Who are the competitors of Dr. Agarwal’s Health Care Limited?
Competitors include other prominent eye care providers and hospital chains specializing in ophthalmology. Comparing the company’s financials and market position can provide insights into its competitive edge.
- How will the IPO impact Dr. Agarwal’s Health Care Limited?
The IPO is expected to enhance the company’s capital base, enabling it to expand operations, invest in new technologies, and strengthen its market position in the eye care sector.
- Is Dr. Agarwal’s Health Care Limited IPO a good investment?
Whether it’s a good investment depends on your financial goals, risk tolerance, and market conditions. It’s advisable to consult a financial advisor and analyze the company’s fundamentals before investing.
- How can I track updates about the IPO?
Updates about the IPO can be tracked on financial news platforms, stock exchange websites, and the company’s official announcements.
